Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00380003 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of EVT 201 to Treat Insomnia
A Phase 2 study, sponsored by Evotec Neurosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 66
- Enrollment target
NCT00380003: Completed Phase 2 study, sponsored by Evotec Neurosciences.
NCT00380003 is a Phase 2 study that has completed, run by Evotec Neurosciences. The registered enrollment target is 66 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00380003, a Phase 2 study, has completed, sponsored by Evotec Neurosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other significant contributing factor, such as depression).
Interventions
- DRUG EVT 201
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2006-09 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
What the finished NCT00380003 record still lists
NCT00380003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 66 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (50% lower).
The record links to 0 conditions, and to 1 intervention - of which EVT 201 is the first listed.
NCT00380003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00380003 about?
NCT00380003 is a clinical study titled "Efficacy Study of EVT 201 to Treat Insomnia". The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating people diagnosed with primary insomnia ( difficulty sleeping with no other significant contributing factor, such as depression).
What is the current status of trial NCT00380003?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 66 participants. The study started on 2006-09. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00380003?
The interventions under investigation include: EVT 201 (DRUG).
Who is sponsoring clinical trial NCT00380003?
This trial is sponsored by Evotec Neurosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00380003's enrollment target sits among peer trials
66 975th of 2000 higher than 1,014 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02584244 · 66 participants · Phase 1
Feasibility of the LUM Imaging System for Detection of Gastrointestinal Cancers
- NCT03067051 · 66 participants · Phase 1
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
- NCT03754725 · 66 participants · Phase 1
Ferritin and Iron Burden in SAH sIRB
- NCT03875378 · 66 participants · Phase 2
Transdermal Estrogen in Women With Anorexia Nervosa
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia